[Effect of decapeptyl (D-TrpG GnPh) on estrogen receptors, progesterone receptors and tissue levels of estrogens (non-conjugated and sulfate-conjugated) in patients with uterine myoma].
Concentrations of estrogen receptors, progesterone receptors, unconjugated estrogens (estradiol and estrone) and sulfate-conjugated estrogens (estradiol sulfate and estrone sulfate) were determined in patients treated with Decapeptyl and in controls. After prolonged Decapeptyl therapy, a highly significant fall in progesterone receptors was evidenced; estrogen receptors were found to be decreased in the myoma as compared with the secretory phase in controls and in the myometrium as compared with the proliferative phase in controls. Tissue levels of estrone sulfate and estradiol sulfate decreased very substantially. In conclusion, Decapeptyl emerges as a very promising agent for the treatment of uterine myomas.
Pasqualini
J R
JR
CNRS, URA-548, Paris, France.
Cornier
E
E
Grenier
J
J
Vella
C
C
Schatz
B
B
Netter
A
A
D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use; D004967:Estrogens / Q000032:analysis; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007889:Leiomyoma / Q000737:chemistry / Q000188:drug therapy*; D009215:Myometrium / Q000737:chemistry; D011959:Receptors, Estradiol / Q000187:drug effects*; D011980:Receptors, Progesterone / Q000187:drug effects*; D017329:Triptorelin Pamoate; D014594:Uterine Neoplasms / Q000737:chemistry / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004967:Estrogens; D011959:Receptors, Estradiol; D011980:Receptors, Progesterone; D017329:Triptorelin Pamoate; D007987:Gonadotropin-Releasing Hormone
Action du décapeptyl (D-Trp6GnRH) sur les récepteurs oestrogeniques, les récepteurs de la progestérone et sur la concentration tissulaire d'oestrogènes (non-conjugués et sous forme sulfate) chez des patientes atteintes de fibrome utérin.